Search
for
Sort by
Research 511–540 of 1000+
- Acne-associated syndromes: models for better understanding of acne pathogenesis
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Epidemiology, Diagnosis, and Treatment of Atopic Dermatitis in the Developing Countries of Asia, Africa, Latin America, and the Middle East: A Review
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Endocrine Influences on Hair Growth
- Telogen effluvium
- The Inflammatory Caspases-1 and -11 Mediate the Pathogenesis of Dermatitis in Sharpin-Deficient Mice
- COVID-19: Understanding Inter-Individual Variability and Implications for Precision Medicine
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- How to diagnose a lipodystrophy syndrome
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Diagnosis and Management of Alopecia in Children
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease
- A preliminary study of finasteride in Tourette syndrome
- Systematic approach to hair loss in women
- Acquired scalp alopecia. Part I: A review
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects
- Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up
- Current management strategies for cutaneous T-cell lymphoma
- Pregnancy and the Skin
- Syphilis: A great imitator
- Skin disease in pregnancy
- <i>Hedychium spicatum</i>: a systematic review on traditional uses, phytochemistry, pharmacology and future prospectus
- Psychotropic Medication and Drug-Related Alopecia
- Trichotillomania in Children
- Idiopathic CD4+ T-lymphocytopenia
- Nonvascular Complications of Injectable Fillers—Prevention and Management
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Riboflavin-responsive glutaryl CoA dehydrogenase deficiency